The press release lacks any financial details, making the immediate revenue impact unquantifiable. Monitor future filings for milestone achievements or royalty revenue recognition, and watch for Crystal Crop's IPO progress (DRHP filed Dec 2025) which could provide additional context on the partnership's value.
Price Chart
Executive Summary
Cibus announced a collaboration with Crystal Crop Protection to develop gene-edited traits in Brassica juncea (mustard) for the Indian market. Crystal Crop will receive an exclusive license in India, leveraging its distribution network of over 14,800 partners. The deal aligns with India's National Mission on Edible Oils, but no upfront payments, milestones, or royalty rates were disclosed.
Key Facts
- Crystal Crop and Cibus will collaborate to develop gene-edited traits in Brassica juncea (mustard).
- Crystal Crop receives an exclusive license to evaluate and commercialize such traits in India.
- Crystal Crop has a network of more than 14,823 independent distribution partners across 23 states and four union territories in India as of March 31, 2026.
- India's National Mission on Edible Oils - Oilseeds aims to raise oilseed harvest from ~39 million tonnes (2022-23) to ~70 million tonnes by 2030-31.
- India's 2022 regulatory determination exempts gene-edited crops (no foreign DNA) from GMO rules.
- No financial terms (upfront payments, milestones, or royalties) were disclosed in the press release.
Financial Impact
No financial terms disclosed; deal is a collaboration and exclusive license with no stated upfront payment, milestone, or royalty amounts.
Risk Factors
- No disclosed financial terms — revenue potential from this deal is uncertain.
- Regulatory or commercial adoption risks in India's mustard market.
- Cibus may need additional near-term funding as noted in forward-looking statements.
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3370249 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 28, 2026 29d ago | Press Release | $1.55 $1.38 | ▼ −10.97% | ▼ −11.68% | $1.38 (−10.97%) |
Jun 11, 2026 19w ago | Institutional Cluster | $1.25 $1.90 | ▲ +52.00% | ▲ +50.11% | $1.38 (+10.40%) |
Jun 9, 2026 20w ago | 8-K | $1.23 $1.50 | ▲ +21.95% | ▲ +20.50% | $1.38 (+12.20%) |
Jun 8, 2026 20w ago | Press Release | $1.23 $1.50 | ▲ +21.95% | ▲ +20.50% | $1.38 (+12.20%) |
May 26, 2026 22w ago | EFFECT | $1.43 $1.38 | ▲ +3.50% | ▲ +1.55% | $1.38 (+3.50%) |
May 14, 2026 23w ago | 8-K | $1.31 $1.27 | ▼ −3.05% | ▼ −5.17% | $1.38 (+5.34%) |
May 4, 2026 25w ago | Press Release | $1.49 $1.47 | ▼ −1.34% | ▼ −6.99% | $1.38 (−7.38%) |
Apr 20, 2026 27w ago | DEFA14A | $1.49 $1.28 | ▼ −14.09% | ▼ −19.01% | $1.38 (−7.38%) |
Mar 26, 2026 30w ago | 424B5 | $1.88 $1.49 | ▲ +20.74% | ▲ +33.49% | $1.38 (+26.60%) |
Mar 26, 2026 30w ago | Press Release | $2.13 $1.50 | ▼ −29.58% | ▼ −40.24% | $1.38 (−35.21%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers